Compare · EW vs WBX
EW vs WBX
Side-by-side comparison of Edwards Lifesciences Corporation (EW) and Wallbox N.V. (WBX): market cap, price performance, sector, and recent activity on the wire.
Summary
- EW operates in Health Care, while WBX operates in Consumer Discretionary - the two are in different parts of the market.
- EW is the larger of the two at $51.75B, about 739.3x WBX ($70.0M).
- EW has hit the wire 3 times in the past 4 weeks while WBX has been quiet.
- EW has more recent analyst coverage (25 ratings vs 14 for WBX).
- Company
- Edwards Lifesciences Corporation
- Wallbox N.V.
- Price
- $89.79+0.00%
- $3.15-10.13%
- Market cap
- $51.75B
- $70.0M
- 1M return
- +7.21%
- -
- 1Y return
- +11.02%
- -
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- NYSE
- NYSE
- IPO
- News (4w)
- 3
- 0
- Recent ratings
- 25
- 14
Edwards Lifesciences Corporation
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides surgical heart valve therapy products, such as pericardial valves for aortic and mitral surgical valve replacement; aortic heart valves; annuloplasty rings; cardiac cannula devices; beating heart mitral valve repair system for the treatment of degenerative mitral regurgitation, as well as various procedure-enabling platforms to advance minimally invasive surgery. In addition, it offers critical care products, such as hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; pulmonary artery catheters; arterial pressure monitoring products, oximetry central venous catheters, as well as monitoring platforms that display a patient's physiological information; and Acumen Hypotension Prediction Index, which alerts clinicians in advance of a patient developing low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
Wallbox N.V.
Wallbox N.V., a technology company, creates electric vehicle charging and energy management systems that redefine users' relationship to the grid. It provides a portfolio of charging and energy management solutions for residential, semi-public, and public use worldwide. The company was founded in 2015 and is based in Barcelona, Spain.
Latest EW
- CVP, TAVR Lippis Daniel J. exercised 619 shares at a strike of $72.68 and sold $56,967 worth of shares (619 units at $92.03) as part of a pre-agreed trading plan (SEC Form 4)
- SEC Form S-8 filed by Edwards Lifesciences Corporation
- SEC Form 10-Q filed by Edwards Lifesciences Corporation
- CVP, JAPAC Markowitz Wayne sold $12,588 worth of shares (146 units at $86.03), decreasing direct ownership by 0.67% to 21,534 units (SEC Form 4)
- CVP, JAPAC Markowitz Wayne exercised 9,628 shares at a strike of $74.02 and sold $818,958 worth of shares (9,628 units at $85.06) (SEC Form 4)
- UBS initiated coverage on Edwards Lifesciences with a new price target
- CEO Zovighian Bernard J gifted 320 shares, received a gift of 320 shares and sold $245,134 worth of shares (2,921 units at $83.93), decreasing direct ownership by 0.32% to 98,845 units (SEC Form 4)
- Edwards Lifesciences upgraded by Leerink Partners with a new price target
- Edwards Lifesciences Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Edwards Lifesciences Reports Second Quarter Results
Latest WBX
- SEC Form F-1 filed by Wallbox N.V.
- SEC Form 6-K filed by Wallbox N.V.
- Wallbox Announces Second Quarter 2026 Financial Results
- Wallbox and Turning Point Energy Surpass 10,000 EV Chargers Deployed Across Saudi Arabia
- Wallbox Announces Timing of its Second Quarter 2026 Financial Results
- Wallbox Announces NYSE Acceptance of Plan to Regain Compliance with Continued Listing Standards
- SEC Form 6-K filed by Wallbox N.V.
- Director Mera Francisco Jose Riberas bought $1,364,504 worth of Class A Ordinary Shares (501,361 units at $2.72) (SEC Form 4)
- Director Aguera Pedro Alonso bought $1,364,504 worth of Class A Ordinary Shares (501,361 units at $2.72) (SEC Form 4)
- Chief Executive Officer Escorsa Enric Asuncion bought $886,929 worth of Class A Ordinary Shares (325,885 units at $2.72) (SEC Form 4)